Extended Long-Term Safety Study of KW-6500 (6500-005)
Phase 3
- Conditions
- Parkinson's Disease
- Registration Number
- JPRN-jRCT2080220981
- Lead Sponsor
- Kyowa Hakko Kirin Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patients who have given written informed consent
- Patients who have completed the 6500-004 study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method